To determine the growth and neurodevelopmental outcome, as well as predictors of the latter in extremely low-birth-weight (ELBW) infants with definitive necrotizing enterocolitis (NEC).
INTRODUCTION
Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease with significant mortality and morbidity affecting predominantly preterm infants, and in particular those extremely low-birth-weight (ELBW) infants less than 1000 g. 1 The reported incidence varies between 9 and 14% with mortality rates as high as 50% in more advanced disease. 1, 2 The pathogenesis of NEC is unclear and likely due to multiple factors including vascular compromise with subsequent rapid increase in feedings leading to bacterial overgrowth, sepsis with release of inflammatory mediators, and/or hemodynamic instability. 3 The clinical expression of NEC reflects a heterogeneous disease process with some infants manifesting localized intestinal injury, while others presenting with diffuse involvement and fulminate necrosis of the intestines. The clinical course of NEC can be divided into two phases. The first is an acute phase characterized by hemodynamic instability and sepsis followed by a second convalescent phase in surviving infants characterized by feeding intolerance, recurrent infections, and prolonged hospital stay. Many factors/events during the acute and convalescent phase may affect the long-term outcomes of NEC infants. Although the outcome of survivors with NEC has been the subject of several studies [4] [5] [6] these have largely been confined to the ''larger'' premature infant. The direct consequence of NEC on the growth and neurodevelopmental outcome of ELBW infants is not as well characterized. Thus, the aim of this study was to evaluate the growth and neurodevelopmental outcome of ELBW infants with definite NEC as compared to infants without NEC, and to determine predictors that might be associated with adverse neurodevelopmental outcome.
METHODS
This was a retrospective case -control analysis. All singleton ELBW infants <1000 g without congenital anomalies, born at Parkland Memorial Hospital between 1995 and 1998, and with a history of Stage 2 or 3 NEC as defined by Bell's criteria were included for analysis. 7 In brief, Bell's Stage 1 represents suspect cases with abdominal distention and ileus, Stage 2 represents definite cases with gastrointestinal bleeding, pneumatosis intestinalis, or portal venous gas, and Stage 3 represents advanced cases with all the above criteria and in addition septic shock and pneumoperitoneum. Infants were identified using a neonatal registry that is run and maintained by the division of neonatology at the University of Texas Southwestern Medical Center. Using the registry, infants with NEC were matched by birth weight (±100 g), gestational age (±1 week) and the nearest birth date to three singleton infants with no history of definite NEC or congenital anomalies. A total of 51 infants comprised the control group. Infant demographic and outcome data were retrieved from the registry. In addition, charts were retrieved and reviewed by one of the authors (L.S.) to confirm the NEC staging and to identify the organisms associated with each sepsis episode. The demographic data include birth weight, gestational age as determined by modified Ballard exam, gender, race, mode of delivery, antenatal steroids therapy, 5 minutes Apgar score, history of substance abuse, and length and fronto-occipital head circumference (FOC) at birth.
NEC and control infants were compared with respect to the following outcome parameters: hyaline membrane disease (HMD), defined as respiratory distress with increasing oxygen requirement and diagnostic radiographic findings, and in the absence of other causes of respiratory distress; pulmonary hemorrhage; incidence of symptomatic patent ductus arteriosus (PDA), defined on clinical criteria and an abnormal echocardiogram; indomethacin therapy; evidence of severe intraventricular hemorrhage (IVH) (grade 3 and 4), 8 cystic periventricular leukomalacia and evidence of nonhemorrhagic lateral ventriculomegaly on discharge head ultrasound (HUS) 9 as interpreted by the attending pediatric radiologist at the time of examination; culture proven nosocomial sepsis; retinopathy of prematurity graded according to international criteria; 10 death defined as death prior to hospital discharge; chronic lung disease (CLD) defined as an oxygen requirement at 36 weeks postmenstrual age in surviving infants; postnatal steroids use for CLD, number of intubation days and duration of hospital stay in infants who survived to discharge; discharge weight, height, and discharge FOC. Feeding practices related to the reinitiation and advancement in NEC infants are similar to that of the non-NEC infants, and follows an established nursery protocol with an incremental increase of 10 to 15 cm 3 /kg/day. All ELBW surviving infants received primary follow-up care in a dedicated low-birth-weight clinic under the supervision of a neonatologist, a psychologist, and a specialized dietitian. Formal neurodevelopmental testing was conducted at a corrected age of 18 to 22 months. Data abstracted from the low-birth-weight medical record and stored in the registry include growth parameters (weight, height, FOC), neurologic exam, and the Bayley Scales of Infant Development, 2nd edition (BSID-II). BSID-II included the mental development index (MDI) and the psychomotor development index (PDI) performed by a certified examiner experienced in the BSID-II test procedures. The MDI assesses memory, problem solving, discrimination, classification, language, and social skills. The PDI assesses control of gross and fine muscle group including walking, running, jumping, use of writing implements, and imitation of hand movements. Mean scores for the MDI and PDI are 100 with a standard deviation (SD) of 15. The neurologic exam included an evaluation of tone, strength, fine motor function, and reflexes. Infants were scored as normal if no abnormalities were noted on the neurologic exam. Growth percentiles were determined using the Babson curves at hospital discharge, 11 and the Infant Health and Development Program percentiles at 18 to 22 months corrected age evaluation. 12 
STATISTICAL ANALYSIS
Differences between the cases and controls were assessed by w 2 analysis or Fisher's exact test for categorical data, and Student's ttest or Mann-Whitney rank-sum test when normality failed for continuous data. To determine the best predictor of an abnormal PDI and MDI, two multiple regression models were generated. PDI was the dependent variable for one model and MDI for the second. Birth weight, gestational age, presence or absence of NEC, history or absence of culture proven nosocomial sepsis, and presence or absence of CLD were included as the independent variables. Both logistic regression models are well-fit based on the HosmerLemeshow test. Sigma Stat 2.0 software package was used in all analyses (SPSS, Chicago, IL). All tests are two-tailed with Type I error set at 5%.
This study was approved by the Human Subjects Review Boards at the University of Texas Southwestern Medical Center.
RESULTS
Between January 1995 and December 1998, 185 singleton ELBW infants <1000 g without congenital anomalies were born and resuscitated. In all, 17 (9%) infants developed Stage 2 or 3 NEC and constitute the cases in this report, 11 (6%) infants developed Stage 1 NEC, and 157 (85%) infants had no history of NEC. A total of 51 infants of the 157 constituted the control group. The control group was similar to the entire cohort of infants with no NEC with respect to birth weight and gestational age, 781±118 vs 793±128 and 27±2 vs 26±2, respectively.
Clinical Characteristics
The demographic characteristics of the NEC and control infants are displayed in Table 1 . There was no difference in the birth weight, median gestational age, gender and race distribution, mode of delivery, antenatal steroid therapy, 5 minutes Apgar score, illicit drug use, and length and head circumference at birth.
Significant clinical outcomes of NEC and control infants are displayed in Table 2 . There were no differences between NEC and control infants in the incidence of HMD, pulmonary hemorrhage, PDA, indomethacin therapy, severe IVH, Stage 3 or 4 retinopathy of prematurity, steroid therapy for ventilator-dependent CLD, abnormal HUS in surviving infants at discharge, or death. Of the NEC survivors six had Stage 2 disease and seven had Stage 3 disease requiring exploratory laparotomy. Four of the infants with Stage 3 NEC were labeled as short gut syndrome. Infants with NEC were intubated for more days and were more likely to progress to CLD. Regarding the abnormal HUS at discharge, in the two NEC infants ventriculomegaly was common to both, and in the control group four infants had ventriculomegaly, three had evidence of cystic periventricular leukomalacia, and two had persistent increased periventricular white matter echogenicity. The four deaths in the index cases were the result of fulminant NEC. In the controls the 15 deaths were the result of immaturity (n ¼ 2), HMD (n ¼ 2), CLD (n ¼ 2), respiratory failure (n ¼ 2), suspect pulmonary hypoplasia (n ¼ 1), pulmonary hemorrhage (n ¼ 1), and severe IVH (n ¼ 5).
The proportion of infants with culture-proven nosocomial sepsis was higher in the NEC group (Table 2 ). This translated into 16 episodes of culture-proven sepsis in the NEC group as compared to 14 episodes in the control group. Only three of the culture-proven septic episodes occurred during the primary NEC episode. Of the organisms isolated from the NEC infants 50% were Gram-negative bacilli (three Klebsiella, two Enterobacter, one Escherichia coli, one Serretia marcescens, and one Citrobacter species) as compared to 14% in the controls (one Klebsiella and one E. coli sp); 44% of the organisms isolated from the NEC cases were grampositive cocci (seven coagulase-negative Staphylococcus) as compared to 72% in the controls (nine coagulase-negative Staphylococcus, and one S. aureus). Fungal infections occurred in 6% of the NEC cases as compared to14% in the controls (one vs two Candida species). The difference in the Gram-negative infections distribution between the two groups was not significant (p ¼ 0.06).
Hospital stay and discharge anthropometrics are listed in Table 3 . NEC survivors had a longer hospital stay and at discharge weighed more, were of greater length, and had larger head circumferences as compared to control infants. However, the weight gain per day and the proportion of infants <5th percentile for weight, height, and FOC were similar in both groups.
Neurodevelopmental Outcome
Neurodevelopmental assessment was performed in all 13 surviving infants with NEC at a mean-adjusted age of 18.4. months (range 17.5 to 20) and for 32 control infants at a mean-adjusted age of 18.4 months (range 17.7 to 20.5). One infant in the NEC case could not undergo the BSID-II secondary to severe disability, and parents refused testing for one control infant. However, growth and neurologic exam data were available for both infants. Three control infants were lost to follow-up. Table 4 summarizes the neurodevelopmental outcome of both NEC and control infants. When compared to controls, infants with NEC had significantly a lower mean PDI and a higher proportion of PDI <85 and <70. In contrast, there were no differences in the MDI between either groups, or the proportion of infants with MDI one or two SD below the mean. There were no differences in the PDI and MDI between Stages 2 and 3 NEC infants (data not shown).
Consistent with the PDI results, seven (54%) of infants with NEC had an abnormal neurologic exam compared to three (9%) controls (Table 4) . Specifically, in the NEC group, there were four infants with generalized hypotonia, one with spastic quadriplegia, 
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Necrotizing Enterocolitis, Neurodevelopmental Outcome and Growth one with spastic diplegia, and one with spastic hemiplegia. In the control group two infants presented with spastic quadriplegia and one infant with spastic diplegia. One infant was blind in the NEC group and no infant in either group was completely deaf.
Relationship between the Discharge Cranial Ultrasound Abnormalities and the Follow-up Examination
Both the NEC infants with ventriculomegaly exhibited significant abnormalities at follow-up, that is, the PDI and MDI were <85 in both. In addition, one infant had a spastic diplegia and the second infant exhibited diffuse hypotonia. Of the nine control infants with an abnormal discharge HUS, three were lost to follow-up; however, all the remaining six infants exhibited one or more abnormalities. In two infants, the PDI and MDI were both <85 and one of the infants in addition exhibited a spastic quadriplegia. In three infants, the MDI was <85 with the PDI >85; one of those infants in addition exhibited a mild quadriplegia. Finally, in one infant, the PDI was <85 and the MDI >85 without abnormalities noted on the clinical examination.
Follow-up Anthropometric Data
The anthropometric data at 18 to 22 months adjusted age are listed in Table 5 . In contrast to the discharge values, infants with NEC had significantly lower weight, height, and smaller FOC. To adjust for the different ages at follow-up, the growth percentiles were determined. The proportion of infants with FOC <5th percentile and height <5th percentile were significantly more common in the NEC vs control infants, however no difference in weight was noted.
Logistic Model
The two multiple logistic regression models designed to determine the best predictor of abnormal PDI or MDI are displayed in Table 6 . The dependent variable for the PDI model was PDI < or >85, and the independent variables were birth weight, gestational age, presence or absence of NEC, CLD, and nosocomial sepsis. The MDI model (Table 6 ) included the same independent variables with MDI < or >85 as the dependent variable. Only NEC was a significant predictor for low PDI with an odds ratio (OR) of 18.5 and confidence interval (CI) of (1.9 to 182.3). CLD was the only significant predictor for a low MDI with an OR of 6.7 and CI of (1.4 to 32.3).
DISCUSSION
The data in this report indicate that ELBW infants with definite NEC (Stage 2 or 3) are at increased risk for neurodevelopmental delay at short-term follow-up, specifically affecting psychomotor function. Approximately 25% of the infants with NEC had an FOC <5th percentile at follow-up and 40% were of short stature. The neonatal course of infants with NEC was significantly more likely to be complicated by a nosocomial infection and progression to CLD. This increased risk for abnormal neurodevelopmental outcome is consistent with prior reports. Thus, Vohr et al. 13 in a review of neonatal factors contributing to adverse neurodevelopmental outcome at 18 to 22 months corrected age, noted NEC to be a significant predictor of an abnormal PDI, but not an abnormal MDI. However, in the larger premature infants, that is, <1500 g with NEC, Sonntag et al. 4 noted mild-to-severe mental retardation in 85% of NEC cases as compared to approximately 50% of the controls.
The findings in this report indicate that NEC is a significant predictor for psychomotor delay. The abnormalities noted on neurologic examination suggest injury to the periventricular white matter in the distribution of the corticospinal tracts. The etiology of this brain injury is unclear and likely multifactorial. Potential incriminating factors include hypoperfusion at the time of the insult, cytotoxic inflammatory mediator release during the systemic infections, stressful environmental conditions and poor postnatal growth. [14] [15] [16] Regarding inflammatory mediators, it is noteworthy that nosocomial infections were significantly more common in the infants with NEC, and in particular Gram-negative infections. There is increasing experimental evidence demonstrating an association between Gram-negative infections and white matter injury. [17] [18] [19] At the cellular level, the preoligodendrocyte is the key target in diffuse white matter injury of microglia through release of reactive oxygen and nitrogen species. 19 Interestingly, brain microglia contain a specific receptor for lipopolysaccharide a critical component of Gram-negative bacteria. 17 Thus, the increased infection rate noted in the NEC patients may be an important mechanism of injury. The cause of this increased infection rate cannot be determined from this retrospective analysis. It would be important to determine in future prospective studies whether this increase is related to the use of central venous lines and prolonged parental nutrition, or to factors intrinsic to NEC.
Regarding the mental development delay, although there were no significant differences between the groups, it is noteworthy that deficits were common to both. Thus 83% of NEC infants and approximately 50% of the controls had evidence of mild-to-severe mental deficit, that is, MDI <85. This suggests a type II error and that a larger sample size is likely necessary to demonstrate a significant difference between the groups. From the logistic model, CLD was the most significant predictor of mental developmental delay which is consistent with prior reports. 13 Neurodevelopmental delay in both the NEC and the control groups was disproportionate to the degree of abnormalities seen on discharge HUS. Only 15% of the NEC infants had an abnormal discharge HUS whereas approximately 80% had either an abnormal PDI and/or MDI (<85). This was less striking in the control infants where 25% had an abnormal HUS at discharge whereas one-third to half had an abnormal PDI and/or MDI, respectively. While cranial ultrasound abnormalities can predict disabling and nondisabling cerebral palsy, 20 up to 30% of ELBW infants with a normal HUS have been reported to have cerebral palsy or severe developmental delay at follow-up. 20, 21 In addition, while neonatal cranial sonographic imaging of low-birth-weight infants has a high reliability in the detection of cystic white matter injury, it is limited in its ability to demonstrate noncystic white matter injury, the kind of injury induced by inflammatory mediators, infection and hypoxia. 19, 20, 22 Indeed, magnetic resonance imaging at discharge from hospital using both conventional and diffusionweighted techniques has been recently shown to better delineate the true extent of white matter abnormalities in this population as compared to cranial sonography. [22] [23] [24] However, the relationship between the white matter injury noted on MRI and subsequent neurodevelopmental outcome at follow-up remains to be determined.
Consistent with the abnormal neurodevelopmental outcome, a head circumference less than the 5th percentile at follow-up was observed in almost one-quarter of the NEC infants vs no control infant. This observation is akin to those of Walsh et al. 6 who noted that one-third of infants with NEC had subnormal head growth compared to 13% of controls. The persistence of poor head growth despite the catch-up in other growth parameters likely reflects the underlying prior brain damage that occurred during hospitalization. Subnormal head growth at 8 months corrected age has previously been shown to be a strong predictor of poor cognitive function, academic achievement and behavior at 8 to 9 years of age. Regarding somatic growth, NEC and control groups had similar weight gain during hospitalization (20 g/day) and the proportion with failure to thrive (birth weight below the 5th percentile) was comparable at discharge, that is, 31% of the NEC infants and 25% of the controls. However, less than 10% of both groups remained so at 18 to 22 months follow-up. These data are similar to those of Sonntag et al. 4 and Ladd et al., 26 who noted no differences between NEC survivors and controls including those infants who required surgery. Failure to thrive in the ELBW population in general is common and anywhere from 40 to 70% of infants are below the 10th percentile at follow-up. [27] [28] [29] Factors attributed to the failure to thrive have included NEC, CLD, postnatal steroids and late-onset sepsis. While the same risk factors were apparent in our patient population, we speculate that this low rate of failure to thrive in the entire cohort may be attributed to the close follow-up of all infants in the specialized ELBW clinic under the close supervision of a dedicated dietitian. 30 In contrast to weight gain, 38% of the NEC infants as compared to only 3% of the controls had short stature, which is consistent with Clark et al., 27 who showed a two-fold increase in a length <10th percentile at hospital discharge in NEC infants. However, two other reports failed to demonstrate such a difference between NEC and controls at follow-up. 4, 6 The reasons for these differences in studies are not clear from this retrospective analysis.
25
In conclusion, this study stressed the importance of definitive NEC and its associated comorbidities as a significant predictor for adverse neurodevelopmental outcome in ELBW infants. Importantly, aggressive nutritional support while essential for catch-up growth is clearly not sufficient to prevent long-term neurodevelopmental morbidities in this group of patients. The occurrence of NEC carries serious short-and long-term consequences not just restricted to local intestinal injury and feeding intolerance. In order to develop strategies and improve the outcome of this high-risk population, future research should focus on both acute and chronic elements of NEC that might contribute to both short-and long-term adverse outcome.
